The effect of obesity and low-dose oral contraceptives on carbohydrate and lipid metabolism

Contraception

Volumn 85, Issue 5, 2012, Pages 446-452

  Beasley, Anitra ^a   Estes, Christopher ^b   Guerrero, Jacqueline ^c   Westhoff, Carolyn ^d  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Carbohydrate metabolism; Lipid metabolism; Obesity; Oral contraceptive pills

Indexed keywords

ETHINYLESTRADIOL PLUS LEVONORGESTREL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CARBOHYDRATE METABOLISM; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LIPID METABOLISM; LOW DRUG DOSE; OBESITY; PROSPECTIVE STUDY;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; CARBOHYDRATE METABOLISM; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CONTRACEPTIVES, ORAL, COMBINED; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ETHINYL ESTRADIOL; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; LEVONORGESTREL; LIPID METABOLISM; MEDICATION ADHERENCE; OBESITY; PATIENT DROPOUTS; TRIGLYCERIDES; YOUNG ADULT;

EID: 84859722865     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2011.09.014     Document Type: Article

References (30)

1. V. Wynn, and I. Godsland Effects of oral contraceptives on carbohydrate metabolism J Reprod Med 31 1986 892 897
2. U.J. Gaspard, and P. Lefebvre Clinical aspects of the relationship between oral contraceptives, abnormalities in carbohydrate metabolism, and the development of cardiovascular disease Am J Obstet Gynecol 163 1963 334 343
3. M. Aurell, K. Cramér, and G. Rybo Serum lipids and lipoproteins during long-term administration of an oral contraceptive Lancet 287 1966 291 293
4. V. Wynn, J.W.H. Doar, and G.L. Mills Some effects of oral contraceptives on serum-lipid and lipoprotein levels Lancet 288 1966 720 723
5. V. Wynn, I. Godsland, and R. Niththyananthan Comparison of effects of different combined oral-contraceptive formulations on carbohydrate and lipid metabolism Lancet 313 1979 1045 1049
6. I. Godsland, D. Crook, and R. Simpson The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism N Engl J Med 323 1990 1375 1381
7. E.B. Rimm, J.E. Manson, and M.J. Stampfer Oral contraceptive use and the risk of type 2 (non-insulin-dependent) diabetes mellitus in a large prospective study of women Diabetologia 35 1992 967 972
8. T.J. Duffy, and R. Ray Oral contraceptive use: prospective follow-up of women with suspected glucose intolerance Contraception 30 1984 197 208
9. L.A. Gillum, S.K. Mamidipudi, and S.C. Johnston Ischemic stroke risk with oral contraceptives JAMA 284 2000 72 78
10. M.J. Stampfer, W.C. Willett, G.A. Colditz, F.E. Speizer, and C.H. Hennekens A prospective study of past use of oral contraceptive agents and risk of cardiovascular diseases N Engl J Med 319 1988 1313 1317
11. N. Dunn, M. Thorogood, and B. Faragher Oral contraceptives and myocardial infarction: results of the MICA case-control study BMJ 318 1999 1579 1584
12. N. Poulter, C. Chang, T. Farley, J. Kelaghan, O. Meirlk, and M. Marmot Acute myocardial infarction and combined oral contraceptives: results of an international multicentre case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception Lancet 349 1997 1202 1209
13. B.C. Tanis, M.A.A.J. van den Bosch, and J.M. Kemmeren Oral contraceptives and the risk of myocardial infarction N Engl J Med 345 2001 1787 1793
14. V.A. Catenacci, J.O. Hill, and H.R. Wyatt The obesity epidemic Clin Chest Med 30 2009 415 444
15. R. Stout Insulin and atheroma - an update Lancet 329 1987 1077 1079
16. K.M. Flegal, M.D. Carroll, C.L. Ogden, and L.R. Curtin Prevalence and trends in obesity among US adults, 1999-2008 JAMA 303 2010 235 241
17. C.L. Westhoff, A.H. Torgal, and E.R. Mayeda Ovarian suppression in normal-weight and obese women during oral contraceptive use: a randomized controlled trial Obstet Gynecol 116 2010 275 283
18. World Health Organization Medical eligibility criteria for contraceptive use 2004 WHO Geneva
19. Resource Centers for Minority Aging Research Assessing insulin sensitivity. RCMAR measurement tools 2006 [cited 2010 January 13]; Available from: http://www.musc.edu/dfm/RCMAR/InsulinSens.html
20. A. Katz, S.S. Nambi, and K. Mather Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans J Clin Endocrinol Metab 85 2000 2402 2410
21. R. Muniyappa, S. Lee, H. Chen, and M.J. Quon Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage Am J Physiol Endocrinol Metab 294 2008 E15 E26
22. American Diabetes Association Diagnosis and classification of diabetes mellitus Diabetes Care 33 2010 S62 S69
23. S.O. Skouby, J. Endrikat, and B. Düsterberg A 1-year randomized study to evaluate the effects of a dose reduction in oral contraceptives on lipids and carbohydrate metabolism: 20 [mu]g ethinyl estradiol combined with 100 [mu]g levonorgestrel Contraception 71 2005 111 117
24. J. Endrikat, C. Klipping, and M. Cronin An open label, comparative study of the effects of a dose-reduced oral contraceptive containing 20 [mu]g ethinyl estradiol and 100 [mu]g levonorgestrel on hemostatic, lipids, and carbohydrate metabolism variables Contraception 65 2002 215 221
25. I.F. Godsland, D. Crook, and V. Wynn Low-dose oral contraceptives and carbohydrate metabolism Am J Obstet Gynecol 163 1990 348 353
26. U. Gaspard Metabolic effects of oral contraceptives Am J Obstet Gynecol 157 1987 1029 1041
27. R.J. Troisi, C.C. Cowie, and M.I. Harris Oral contraceptive use and glucose metabolism in a national sample of women in the United States Am J Obstet Gynecol 183 2000 389 395
28. B.L. Furman Impairment of glucose tolerance produced by diuretics and other drugs Pharmacol Ther 12 1981 613 649
29. W. Sadik, L. Kovacs, and A. Pretnar-Darovec A randomized double-blind study of the effects of two low-dose combined oral contraceptives on biochemical aspects. Report from a seven-centred study: WHO Special Programme of Research, Development and Research Training in Human Reproduction Task Force on Oral Contraceptives Contraception 32 1985 223 236
30. H. Scharnagl, G. Petersen, M. Nauck, A.T. Teichmann, H. Wieland, and W. März Double-blind, randomized study comparing the effects of two monophasic oral contraceptives containing ethinylestradiol (20 [mu]g or 30 [mu]g) and levonorgestrel (100 [mu]g or 150 [mu]g) on lipoprotein metabolism Contraception 69 2004 105 113